Novo Nordisk drug shows greater weight loss in trial
Polish Radio reports the company's candidate outperformed on weight reduction, though trial details and comparator remain thinly described.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 4 20:47 ETSource: polskieradio.pl
The wire
- 01A Novo Nordisk obesity drug produced greater weight loss in a trial, according to the report.
- 02Incretin prescribers and telehealth operators track each Novo readout for where the next approved option lands.
- 03Full endpoint data, dosing and comparator arms were not detailed in the report; treat the result as preliminary until published.
From the source
Read at polskieradio.plnovo nordisk drug shows greater weight loss in trial
